Clinical Trial Update: Adaptive Hypofractionated Radiotherapy for Locally Advanced NSCLC Based on Dynamic Enhanced MRI [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating adaptive hypofractionated radiotherapy guided by dynamic enhanced MRI for locally advanced non-small cell lung cancer; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Sun Yat-sen University | Conditions: Non-small Cell Lung Cancer | Phase 3 | Status: RECRUITING